−0.4574 USD
−5.80 M USD
464.28 K USD
16.23 M
About Lexaria Bioscience Corp.
Sector
CEO
Richard C. Christopher
Headquarters
Kelowna
Website
Founded
2004
FIGI
BBG00YTSHLB5
Lexaria Bioscience Corp. is a biotechnology company, which engages in the provision of active pharmaceutical ingredients through its DehydraTECH drug delivery technology. Its products can be used with APIs fat-soluble vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) pain medications, hormones, phosphodiesterase inhibitors, antivirals, nicotine and its analogs, and all cannabinoids including tetrahydrocannabinol (THC) for therapeutic indications, as well as hypertension, SARS-CoV-2/COVID-19, and HIV/AIDS. It operates through the following segments: IP Licensing, B2B Product, Research and Development, and Corporate. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.